ASX
Paradigm Biopharmaceuticals Limited
PAR:ASX•Healthcare
Sensitive ASX Announcement
Phase 3 OA Trial to Proceed after Formal Safety Review
Published: 28/12/22, 12:06pm (AEST)•2 pages